Journal of Leukocyte Biology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, X. W.
Right arrow Articles by Thorlacius, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, X. W.
Right arrow Articles by Thorlacius, H.
(Journal of Leukocyte Biology. 2000;68:621-626.)
© 2000 by Society for Leukocyte Biology

Linomide abolishes leukocyte adhesion and extravascular recruitment induced by tumor necrosis factor {alpha} in vivo

Xiao Wei Zhang*, Gunnar Hedlund{dagger}, Per Borgström{ddagger}, Karl E. Arfors{ddagger} and Henrik Thorlacius*

* Department of Surgery, Malmö University Hospital, Lund University, Malmö;
{dagger} Active Biotech Research, Lund, Sweden; and
{ddagger} Sidney Kimmel Cancer Center, La Jolla, California

Correspondence: Henrik Thorlacius, Department of Surgery, Malmö University Hospital, Lund University, 20502 Malmö, Sweden.

The immunomodulator Linomide (roquinimex) ameliorates the development of numerous inflammatory and immunological diseases, including sepsis, arthritis, and encephalomyelitis. However, the mechanism underlying this protective effect of Linomide remains unclear. In this study, we wanted to evaluate the effect of Linomide treatment on the different steps in the extravasation process of leukocytes stimulated by tumor necrosis factor {alpha} (TNF-{alpha}) in vivo. For this purpose, we used intravital microscopy in the mouse cremaster muscle microcirculation. We found that pretreatment with Linomide dose-dependently (3–300 mg/kg) reduced TNF-{alpha}-induced leukocyte adhesion and tissue recruitment. Notably, at 300 mg/kg of Linomide, the leukocyte response to TNF-{alpha} was nearly abolished, i.e. leukocyte adhesion was decreased by 83% and recruitment by 86%. In fact, the anti-inflammatory effect of this dose of Linomide corresponded in magnitude to the potency of 10 mg/kg of dexamethasone. Moreover, administration of Linomide did not alter the systemic leukocyte counts. On the other hand, 1–10 mg/kg of dexamethasone decreased the circulating number of mononuclear leukocytes by 77%. Taken together, our novel findings demonstrate that Linomide is a potent inhibitor of leukocyte adhesion and recruitment in cytokine-activated tissues. These data may help explain the documented protection provided by Linomide in inflammatory diseases characterized by cytokine activation and leukocyte accumulation.

Key Words: dexamethasone • microcirculation • P-selectin • rolling




This article has been cited by other articles:


Home page
Infect. Immun.Home page
R. Schramm and H. Thorlacius
Staphylococcal Enterotoxin B-Induced Acute Inflammation Is Inhibited by Dexamethasone: Important Role of CXC Chemokines KC and Macrophage Inflammatory Protein 2
Infect. Immun., May 1, 2003; 71(5): 2542 - 2547.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Society for Leukocyte Biology.